Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 102,242 |
| Other current assets | 0 | 0 | 0 | 62 |
| TOTAL | $0 | $0 | $0 | $102,304 |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $0 | $0 | $0 | $102,304 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,133 |
| Accrued Expenses | 0 | 0 | 0 | 10,607 |
| TOTAL | $0 | $0 | $0 | $11,740 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $0 | $11,740 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | 0 | -42,306 |
| Other shareholders' equity | 0 | 0 | 0 | 132,620 |
| TOTAL | $0 | $0 | $0 | $90,564 |
| Total Liabilities And Equity | $0 | $0 | $0 | $102,304 |